CONTINENTAL STRATEGY, LLC

Lobbying for DEXCOM · Healthcare company that develops, manufactures, produces, and distributes CGMs.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 19, 2026

Income

$75,000.00

What the client paid this registrant for the period.

Client based in

California

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

continuous glucose monitoring

Medical/Disease Research/Clinical Labs

continuous glucose monitoring

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.